In agreement, it was recently reported that Polζ expression is higher in cervical cancer than in normal tissue; in cervical cancer, the depletion of Rev3L increased cisplatin sensitivity, while Rev3L overexpression conferred cisplatin resistance by decreasing cisplatin-induced apoptosis 80. This evidence concerns the gene REV3L and cervical carcinoma.